Chime Biologics
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Hi-tech Development Zone 388 Gaoxin Road...Phone Number
+86 2787879208Website
www.chimebiologics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Chime Biologics
Based out of Wuhan, China, Chime Biologics is a contract development and manufacturing company.Explore more
Chime Biologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Chime Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Chime Biologics launches new products
Earning: See what the market has to say on Chime Biologics recently announced quarterly report
Chime Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Chime Biologics
Click to see if Chime Biologics had a recent Job posting/layoffs
Check out if Chime Biologics is spiking on competitors!
Check if Chime Biologics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Chime Biologics has new funding data
Recommended Actions
Reach out to Masked Content who joined Chime Biologics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Chime Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Chime Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Chime Biologics.
Chime Biologics financials insights
Gather financial insights about Chime Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$190M
Chime Biologics Tech Stack
A closer look at the technologies used by Chime Biologics
See more technologies
Most Recent Scoops
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Spending/Investment, Capacity Planning, Artificial Intelligence, Manufacturing Operations
Project
IT Audit / Compliance, Information Security, Compliance, Security
Funding
New Hire
Executive Move
Chime Biologics News & Media
Chime Biologics Supports Mabgeek to Enter the U.S. Phase III Trials for MG-K10
SHANGHAI, Feb. 21, 2025 /PRNewswire/ -- Chime Biologics, a leading global CDMO that enables its partners' success in biologics, today announced its continued collaboration with Mabgeek in advancing MG-K10, a potential Best-in-Class therapy, a novel IL-4Rα-targeting antibody drug for...Chime Biologics and Mabgeek Achieve MG-K10 PPQ Milestone, Advancing Atopic Dermatitis and Asthma Therapies Antibody Drug MG-K10 Late-Stage Clinical Trials and Commercialization
Process Performance Qualification (PPQ) validates robust manufacturing standards and is crucial for regulatory compliance Marks a key step forward for the world's first once-monthly IL-4Rα-targeting antibody therapeutic for Th2-driven diseases, with a strategic focus on entering the American and European markets SHANGHAI, Jan. 3, 2025 /PRNewswire/ -- Chime Biologics, a leading global CDMO that enables its partners' success in biologics, and Mabgeek, a clinical-stage innovative antibody drug deveChime Biologics and Waterstone Announce a Strategic Partnership to Empower Antibody-Drug Conjugate (ADC) Development and Manufacturing
Chime Biologics and Waterstone Pharmaceuticals announce a strategic partnership to provide integrated services for the global Antibody-Drug Conjugate (ADC) industry. Chime Biologics will leverage its CMC expertise in biologics to manage Antibody Intermediate, ADC Drug Substance and Drug Product, while Waterstone will supply Linker-payload. WUHAN, China, Nov. 12, 2024 /PRNewswire/ -- Chime Biologics, a leading global CDMO that enables its partners' success in biologics, and Waterstone, a reliableChime Biologics and Korean Listed Company MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing
SHANGHAI, Oct. 28, 2024 /PRNewswire/ -- Chime Biologics, a leading global CDMO that enables its partners' success in biologics, today announced a strategic collaboration with MedPacto, a South Korean clinically staged company listed on KOSDAQ (235980). MedPacto, known for its focus on...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Chime Biologics
Sign Up For FreeTo access detailed company insights
Based out of Wuhan, China, Chime Biologics is a contract development and manufacturing company.... Read More
